🌬️ GOLD ABE Group (COPD)
UseUse to assign group A, B, or E and select initial inhaled therapy in stable COPD.
SourceGOLD Report 2026 — Global Strategy for COPD.
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
From the 2023 revision the former C/D groups merged into a single high-risk group E, simplifying the matrix (original synthesis · not guideline verbatim).
When to use
Use to assign group A, B, or E and select initial inhaled therapy in stable COPD.
How it works
→ group E; with no exacerbation, by symptoms: mMRC 0–1 / CAT <10 → A, mMRC ≥2 / CAT ≥10 → B.
Key points
- From the 2023 revision the former C/D groups merged into a single high-risk group E, simplifying the matrix (original synthesis · not guideline verbatim).
- Airflow-limitation grade (GOLD 1–4 by FEV1%) is reported separately and does not set the letter group.
References
- [Guideline / primary source]GOLD Report 2026 — Global Strategy for COPD.
- [Guideline / primary source]GOLD 2023 — ABE assessment tool revision.
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Exacerbations in the past year | None (0 moderate/severe exacerbations) |
|---|---|
| Symptom burden | mMRC 0–1 (CAT < 10) |
→GOLD groupGroup A
- Exacerbation risk：Low
- Symptoms：Low (mMRC 0–1 / CAT < 10)
| Exacerbations in the past year | ≥1 moderate or severe exacerbation |
|---|---|
| Symptom burden | mMRC ≥ 2 (CAT ≥ 10) |
→GOLD groupGroup E
- Exacerbation risk：High (→ E)
- Symptoms：High (mMRC ≥ 2 / CAT ≥ 10)
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using GOLD ABE Group (COPD)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does GOLD ABE Group (COPD) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is GOLD ABE Group (COPD) calculated in practice? Can you show a worked example?
- Inputs: Exacerbations in the past year None (0 moderate/severe exacerbations), Symptom burden mMRC 0–1 (CAT < 10) → Result: GOLD group Group A（Exacerbation risk: Low, Symptoms: Low (mMRC 0–1 / CAT < 10)） Inputs: Exacerbations in the past year ≥1 moderate or severe exacerbation, Symptom burden mMRC ≥ 2 (CAT ≥ 10) → Result: GOLD group Group E（Exacerbation risk: High (→ E), Symptoms: High (mMRC ≥ 2 / CAT ≥ 10)）